SHILPA MEDICARE LIMITED

SHILPA MEDICARE LIMITED Company Profile

SHILPA MEDICARE LIMITED is a leading Indian pharmaceutical company primarily engaged in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company has a strong global presence, especially in the oncology segment, and is known for its advanced manufacturing capabilities and robust R&D initiatives.

Nature of Business:

SHILPA MEDICARE LIMITED is a MANUFACTURER (Factory).

The company operates its own state-of-the-art manufacturing facilities that produce a wide range of pharmaceutical products, including complex APIs, intermediates, and various finished dosage forms such as tablets, capsules, and injectables. These facilities are regularly audited and approved by major international regulatory bodies, including the US FDA, EDQM, and others, affirming their adherence to global quality standards. They are not a trading company; their core business revolves around in-house production and innovation.

Key Activities and Products:

Manufacturing of Active Pharmaceutical Ingredients (APIs), with a significant focus on oncology and non-oncology therapeutic areas.

Development and production of Finished Dosage Forms (FDFs) for various markets worldwide.

Contract Research and Manufacturing Services (CRAMS).

Biologics and biosimilars development.

Headquarters: Raichur, Karnataka, India.

Shilpa Medicare Limited, an Indian company, manufactures and sells the following products:

* **APIs (Active Pharmaceutical Ingredients):** Oncology, Non-Oncology, and custom synthesis.

* **Formulations:** Oncology injectables, oral solids, and liquids. Non-Oncology injectables and oral solids.

* **Biosimilars:** Developing and manufacturing biosimilar products.

* **Research and Development:** New drug discovery and development.

* **Sterile Products:** Injectables

* **Oral Solids:** Tablets and Capsules

* **Liquid Orals:** Syrups and suspensions